SEC Form 4 · accession 0001179110-15-009967
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Walter Peltz
Officer — Chief Executive Officer · Director
Period of report
Jun 17, 2015
Accepted (ET)
Jun 17, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 17, 2015 | M | 3,500 | $10.85 | A | 7,276 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.85 | Jun 17, 2015 | M | 3,500 | D | — | May 15, 2023 | Common Stock | 3,500 | 353,030 | D |
| Stock Option (Right to Buy)F2 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 110,694 | 110,694 | D |
| Stock Option (Right to Buy)F3 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 200,000 | 200,000 | D |
| Stock Option (Right to Buy)F4 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 300,000 | 300,000 | D |
| Stock Option (Right to Buy)F5 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 416 | 416 | D |
| Stock Option (Right to Buy)F6 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 541 | 541 | D |
| Stock Option (Right to Buy)F6 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 583 | 583 | D |
| Stock Option (Right to Buy)F6 | $451.20 | holding | — | — | — | — | May 15, 2019 | Common Stock | 583 | 583 | D |
| Stock Option (Right to Buy)F6 | $735.60 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 293 | 293 | D |
| 2018-04-01F6 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 708 | 708 | D |
| Stock Option (Right to Buy)F6 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 322 | 322 | D |
| Stock Option (Right to Buy)F6 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 136 | 136 | D |
Explanation of responses
- F1This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- F2This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- F3This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F4This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F5This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
- F6Currently exercisable.